Stocksigma LogoStocksigma Logo

Navin Fluorine Reports Robust Q1 FY27 Growth and Outlines Capex Roadmap

Navin Fluorine scheduled physical analyst meetings at the Jefferies India Forum on 16th–17th Sep'26. In Q1 FY27, consolidated net sales grew 44% YoY (+11%

Navin Fluorine Reports Robust Q1 FY27 Growth and Outlines Capex Roadmap

Navin Fluorine International Ltd · Intimation · 07 Sept 2026, 6:20 pm

Navin Fluorine Reports Robust Q1 FY27 Growth and Outlines Capex Roadmap Navin Fluorine scheduled physical analyst meetings at the Jefferies India Forum on 16th–17th Sep'26. In Q1 FY27, consolidated net sales grew 44% YoY (+11% QoQ) to Rs. 1,045.1 Cr, while Operating EBITDA rose 73% YoY to Rs. 357.1 Cr with margins at 34.2%. Operating PAT surged 108% YoY to Rs. 243.3 Cr. Segment YoY revenue grew across CDMO (+82%), Specialty Chemicals (+48%), and HPP (+33%). Key growth capex includes a Rs. 236.5 Cr HFC expansion, Rs. 125 Cr Phase II cGMP4 capacity, and Rs. 90 Cr for Advanced Materials.

Original exchange filing (PDF)

More announcements from Navin Fluorine International Ltd

All Navin Fluorine International Ltd announcements